10q23.3 Loss of heterozygosity is higher in lymph node-positive (pT2-3, N+) versus lymph node-negative (pT2-3, N0) prostate cancer

Human Pathology

Volumn 31, Issue 4, 2000, Pages 504-508

  Rubin, Mark A ^a,b,c   Gerstein, Amy ^a,b   Reid, Kris ^a,b   Bostwick, David G ^a,b   Cheng, Liang ^a,b   Parsons, Ramon ^a,b   Papadopoulos, Nickolas ^a,b  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

10q23; Chromosome 10; Prostate cancer; PTEN MMAC1

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 10Q; DNA DETERMINATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER;

EID: 0034075812     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hp.2000.6713     Document Type: Article

References (33)

1. Trybus T.M. Burgess A.C. Wojno K.J. Distinct areas of allelic loss on chromosomal regions 1Op and 1Oq in human prostate cancer Cancer Res 56 1996 2263 2267
2. Latil A. Baron J.C. Cussenot O. Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q Genes Chromosomes Cancer 11 1994 119 125
3. Lacombe L. Orlow I. Reuter V.E. Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer Int J Cancer 69 1996 110 113
4. Konig J.J. Teubel W. Romijn J.C. Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers Hum Pathol 27 1996 720 727
5. Ittmann M.M. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma Prostate 28 1996 275 281
6. Ittmann M. Allelic loss on chromosome 10 in prostate adenocarcinoma Cancer Res 56 1996 2143 2147
7. Gray I.C. Phillips S.M. Lee S.J. Loss of the chromosomal region 1Oq2325 in prostate cancer Cancer Res 55 1995 4800 4803
8. Komiya A. Suzuki H. Ueda T. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer Genes Chromosomes Cancer 17 1996 245 253
9. Steck P.A. Pershouse M.A. Jasser S.A. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 1Oq23.3 that is mutated in multiple advanced cancers Nat Genet 15 1997 356 362
10. Li J. Yen C. Liaw D. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
11. Wang S.I. Puc J. Li J. Somatic mutations of PTEN in glioblastoma multiforme Cancer Res 57 1997 4183 4186
12. Guldberg P. Straten P.T. Birck A. Disruption of the MMACI/PTEN gene by deletion or mutation is a frequent event in malignant melanoma Cancer Res 57 1997 3660 3663
13. Risinger J.I. Hayes A.K. Berchuck A. PTEN/MMACI mutations in endometrial cancers Cancer Res 57 1997 4736 4738
14. Tashiro H. Blazes M.S. Wu R. Mutations in PTEN are frequent in endometrial carcinoma but tare in other common gynecological malignancies Cancer Res 57 1997 3935 3940
15. Liaw D. Marsh D.J. Li J. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Nat Genet 16 1997 64 67
16. Lynch E.D. Ostermeyer E.A. Lee M.K. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis Am J Hum Genet 61 1997 1254 1260
17. Marsh D.J. Coulon V. Lunetta K.L. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation Hum Mol Genet 7 1998 507 515
18. Marsh D.J. Dahia P.L. Coulon V. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 1Oq22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation Genes Chromosomes Cancer 21 1998 61 69
19. Tsou H.C. Teng D.H. Ping X.L. The role of MMAC1 mutations in early-onset breast cancer: Causative in association with Cowden syndrome and excluded in BRCA1-negative cases Am J Hum Genet 61 1997 1036 1043
20. Eng C. Genetics of Cowden syndrome: Through the looking glass of oncology Int J Oncol 12 1998 701 710
21. Rhei E. Kang L. Bogomolniy F. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinoma Cancer Res 57 1997 3657 3659
22. Chen J. Lindblom P. Lindblom A. A study of the PTEN/ MMACI gene in 136 breast cancer families Hum Genet 102 1998 124125
23. Sakurada A. Suzuki A. Sato M. Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary Jpn J Cancer Res 88 1997 1025 1028
24. Ueda K. Nishijima M. Inui H. Infrequent mutations in the PTEN/MMACI gene among primary breast cancers Jpn J Cancer Res 89 1998 17 21
25. Cairns P. Okami K. Halachmi S. Frequent Inactivation of PTEN/MMAC1 in primary prostate cancer Cancer Res 57 1997 4997 5000
26. Suzuki H. Freije D. Nusskern D.R. Interfocal heterogeneity of PTEN/MMACI gene alterations in multiple metastatic prostate cancer tissues Cancer Res 58 1998 204 209
27. Vlietstra R.J. van Alewijk D.C. Hermans K.G. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts Cancer Res 58 1998 2720 2723
28. Wang S.I. Parsons R. Ittmann M. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas Clin Cancer Res 4 1998 811 815
29. Whang Y.E. Wu X. Suzuki H. Inactivation of the tumor suppressor PTEN/MMACI in advanced human prostate cancer through loss of expression Proc Natl Acad Sci U S A 95 1998 5246 5250
30. Emmert-Buck M.R. Bonner R.F. Smith P.D. Laser capture microdissection Science 274 1996 998 1001
31. Jen J. Kim H. Piantadosi S. Allelic loss of chromosome 18q and prognosis in colorectal cancer N Engl J Med 331 1994 213 221
32. Dong J.T. Sipe T.W. Hyytinen E.R. PTEN/MMACI is infrequently mutated in pT2 and pT3 carcinomas of the prostate Oncogene 17 1998 1979 1982
33. Rasheed B.K. Stenzel T.T. McLendon R.E. PTEN gene mutations are seen in high-grade but not in low-grade gliomas Cancer Res 57 1997 4187 4190